GLP-1 sourcing
Organize the GLP-1 sourcing questions before the next sales conversation.
Product interest alone does not define a workable clinic relationship. Use the sourcing brief to document where you operate, how the program works and what your team needs to evaluate.
Questions to bring into the search
- Which entity would provide the pharmacy service?
- Which states and clinic models can it support?
- What prescription and patient-specific requirements apply?
- How does onboarding work?
- What fulfillment workflows are supported?
- Which product details and quality documents are available for review?
- What are the current pricing, minimums and payment terms?
- How are shipping, temperature excursions and service issues handled?
- Who owns the ongoing clinic relationship?
Product pathways
Compounded semaglutide and tirzepatide are patient-specific prescriptions prepared by a licensed pharmacy on a prescriber’s order, and compounded drugs are not FDA approved.
Semaglutide sourcing
What the review looks at, dated regulatory context and a brief preset for compounded semaglutide, which is not FDA approved.
Tirzepatide sourcing
What the review looks at, dated regulatory context and a brief preset for compounded tirzepatide, which is not FDA approved.
Turn the checklist into your clinic brief.
For licensed clinics and prescribers. Do not submit patient or medical information.